SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 763.15 |
| Enterprise Value ($M) | 13.69 |
| Book Value ($M) | 1,114.77 |
| Book Value / Share | 2.91 |
| Price / Book | 0.68 |
| NCAV ($M) | 879.52 |
| NCAV / Share | 2.30 |
| Price / NCAV | 0.87 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.04 |
| Return on Assets (ROA) | 0.04 |
| Return on Equity (ROE) | 0.05 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 26.75 |
| Current Ratio | 27.80 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 918.58 |
| Assets | 1,153.83 |
| Liabilities | 39.06 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 117.61 |
| Operating Income | -54.27 |
| Net Income | 41.08 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 18.84 |
| Cash from Investing | 175.15 |
| Cash from Financing | -1.23 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Altria Group, Inc. | 41.00 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 846,029 | 3,725,459 | 22.71 | |
| 522,941 | 1,451,829 | 36.02 | |
| 554,020 | 1,440,150 | 38.47 | |
| 817,468 | 2,002,084 | 40.83 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CLSD – Clearside Biomedical, Inc. | CLYM – Climb Bio, Inc. |
| CRMD – CorMedix Inc. | CRSP – CRISPR Therapeutics AG |
| CRVS – Corvus Pharmaceuticals, Inc. |